Cargando…

LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common malignancies globally and the second leading cause of cancer-related death. Low-density lipoprotein (LDL) receptor-related protein 1B (LRP1B) is one of the commonly mutated genes in HCC, but its role in HCC remains unclear. In this study, we a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fahui, Hou, Wanyun, Liang, Jiadong, Zhu, Lilan, Luo, Chunying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176260/ https://www.ncbi.nlm.nih.gov/pubmed/34093808 http://dx.doi.org/10.7150/jca.53124

Ejemplares similares

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

LRP1B mutation associates with increased tumor mutation burden and inferior prognosis in liver hepatocellular carcinoma
por: Yu, Ge, et al.
Publicado: (2022)

Prognostic value of LINC02560 in colorectal cancer correlates with tumor microenvironment immunity
por: Luo, Chunying, et al.
Publicado: (2021)

LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
por: Wang, Longrong, et al.
Publicado: (2021)

Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer
por: Hu, Sizhe, et al.
Publicado: (2021)

Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma
por: Xu, Jian, et al.
Publicado: (2021)

Retracted: Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

The Mutation and Expression Level of LRP1B are Associated with Immune Infiltration and Prognosis in Hepatocellular Carcinoma
por: Wang, Mengmeng, et al.
Publicado: (2021)

Construction and Evaluation of a Tumor Mutation Burden-Related Prognostic Signature for Thyroid Carcinoma
por: Lu, Haodong, et al.
Publicado: (2021)

A novel panel based on immune infiltration and tumor mutational burden for prognostic prediction in hepatocellular carcinoma
por: Xie, Chan, et al.
Publicado: (2021)

Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data
por: Liu, Shaoqing, et al.
Publicado: (2021)

Evaluation of tumor mutational burden in small early hepatocellular carcinoma and progressed hepatocellular carcinoma
por: Wong, Mary, et al.
Publicado: (2021)

Integrated Analysis of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma
por: Zhao, Yulan, et al.
Publicado: (2022)

Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma
por: Franses, Joseph W, et al.
Publicado: (2022)

Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma
por: Gabbia, Daniela, et al.
Publicado: (2023)

A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

Spontaneous Immune-Mediated Regression of Hepatocellular Carcinoma With High Tumor Mutational Burden
por: Franses, Joseph W., et al.
Publicado: (2021)

The Effect of Ferroptosis-Related Genes on Prognosis and Tumor Mutational Burden in Hepatocellular Carcinoma
por: Zhang, Hao, et al.
Publicado: (2021)

Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
por: Chen, Hao, et al.
Publicado: (2019)

Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
por: Chen, Hao, et al.
Publicado: (2019)

Diagnosis and prognosis models for hepatocellular carcinoma patient’s management based on tumor mutation burden
por: Tang, Bufu, et al.
Publicado: (2021)

A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden
por: Wu, Fei, et al.
Publicado: (2022)

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis
por: Yin, Lu, et al.
Publicado: (2021)

LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma
por: Cao, Can-hui, et al.
Publicado: (2021)

Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
por: Wen, Fang, et al.
Publicado: (2021)

Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer
por: Zhou, Mengting, et al.
Publicado: (2019)

Tumor mutation burden associated with miRNA-gene interaction outcome mediates the survival of patients with liver hepatocellular carcinoma
por: Yu, Qing-Jiang, et al.
Publicado: (2020)

Novel LRP6 Mutations Causing Non-Syndromic Oligodontia
por: Lee, Yejin, et al.
Publicado: (2022)

A Prognostic Model for Predicting Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Bladder Urothelial Carcinoma
por: Wang, Chengbang, et al.
Publicado: (2022)

Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-Analysis
por: Liu, Shijian, et al.
Publicado: (2009)

Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma
por: Brazel, Danielle, et al.
Publicado: (2023)

Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma
por: Li, Miaomiao, et al.
Publicado: (2020)

Molecular Subtyping and Prognostic Assessment Based on Tumor Mutation Burden in Patients with Lung Adenocarcinomas
por: Wang, Changzheng, et al.
Publicado: (2019)

High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas
por: Mei, Ping, et al.
Publicado: (2020)

LRP1B mutation is associated with tumor immune microenvironment and progression-free survival in lung adenocarcinoma treated with immune checkpoint inhibitors
por: He, Ziyi, et al.
Publicado: (2023)

RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2015)

Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma
por: Song, Ze-Bing, et al.
Publicado: (2021)

Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden
por: Lin, Jiaqiong, et al.
Publicado: (2020)

Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery
por: Moreira, A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lke0fdrm6k0i9hv23tvmajtie1